The FDA has released a draft guidance recommending the reclassification of full-field digital mammography systems from class III to class II. The agency is calling for public comment on the proposal through Aug. 28.
Published in Brief:
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||